Clinical trial
Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome
NCT00290602 · National Cancer Center, Korea, Other · Completed
Key facts
| NCT number | NCT00290602 |
|---|---|
| Title | Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome |
| Official title | Prospective Phase II Study of Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome (ARDS) After Thoracic Surgery (E-START) |
| Lead sponsor | National Cancer Center, Korea, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Respiratory Distress Syndrome, Acute Lung Injury, Postoperative Complications |
| Intervention type | Drug |
| Interventions | Methylprednisolone sodium succinate |
| Enrollment | 40 |
| Start date | Feb 1, 2004 |
| Completion | Dec 1, 2006 |
| First posted | Feb 13, 2006 |
| Last update posted | Jan 17, 2007 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: